Residency · Residency · Interventional Radiology
Intracranial Aneurysm: Endovascular Coiling Fundamentals
Overview
Intracranial aneurysms are focal dilations of cerebral arteries, most commonly saccular (berry) aneurysms. Prevalence: 2-5% of the general population; most are asymptomatic. Subarachnoid hemorrhage (SAH) from ruptured aneurysm: devastating — 30-day mortality ~40%. Endovascular coiling has become the primary treatment modality for most intracranial aneurysms since the ISAT trial (2002).
Aneurysm Classification and Morphology
Types
Saccular (berry): most common (~90%); focal outpouching from vessel wall at branch points. Fusiform: circumferential dilation of a vessel segment; associated with atherosclerosis. Dissecting: from intimal tear with subintimal hemorrhage; may cause SAH or ischemia. Mycotic (infectious): from septic emboli (endocarditis); typically distal vessel location. Traumatic: post-traumatic pseudoaneurysm; may involve any segment.
Common Locations
Anterior communicating artery (AComA): 30-35% (most common overall). Posterior communicating artery (PComA) origin: 25-30%. Middle cerebral artery (MCA) bifurcation: 15-20%. Basilar tip: 5-10%. Other: ophthalmic segment ICA, PICA, pericallosal, SCA.
Morphologic Assessment
Dome-to-neck ratio: fundus diameter / neck width. Ratio >2: favorable for coiling (narrow neck retains coils). Ratio <1.5: wide-neck, may require adjunctive devices (stent or balloon). Aneurysm size classification: Small: <7 mm. Medium: 7-12 mm. Large: 13-24 mm. Giant: ≥25 mm. Neck width: <4 mm (narrow) vs. ≥4 mm (wide). Incorporates branch vessels: complicates treatment strategy.
<image>3D rotational angiography reconstruction showing a saccular anterior communicating artery aneurysm with measurement of dome diameter, neck width, and dome-to-neck ratio for treatment planning</image>
Key Trials
ISAT (International Subarachnoid Aneurysm Trial, 2002)
Ruptured aneurysms randomized to endovascular coiling vs. surgical clipping. Primary outcome: death or dependency at 1 year. Result: coiling superior — absolute risk reduction of 7.4% (23.5% vs. 30.9%). Benefit maintained at 10-year follow-up. Higher retreatment rate with coiling (~17% vs. ~4% for clipping). Limitation: selected population (aneurysms amenable to both treatments).
BRAT (Barrow Ruptured Aneurysm Trial, 2012-2019)
Confirmed ISAT findings: coiling associated with better outcomes for posterior circulation aneurysms. MCA aneurysms: clipping may be preferred (better obliteration rates, lower retreatment). Long-term data: retreatment higher with coiling but overall outcomes comparable.
Unruptured Aneurysm Management
ISUIA (International Study of Unruptured Intracranial Aneurysms): Small (<7 mm) anterior circulation aneurysms in patients without prior SAH: very low rupture risk (~0.1%/year). Posterior circulation and larger aneurysms: higher rupture risk. Treatment risk must be weighed against natural history. PHASES score: predicts 5-year rupture risk based on Population, Hypertension, Age, Size, Earlier SAH, and Site. Treatment generally recommended for: ≥7 mm, symptomatic, posterior circulation, family history, documented growth.
Endovascular Coiling Technique
Access and Navigation
Femoral artery access (6-Fr sheath), guide catheter to ICA or vertebral artery. Microcatheter (1.7-2.3 Fr) and microwire navigated into the aneurysm dome. 3D rotational angiography for working angle selection. Roadmap technique for real-time catheter navigation.
Coil Types
Bare platinum coils: original design (Guglielmi detachable coils — GDC). Bioactive coils: coated with polymers to promote thrombosis and endothelialization (Matrix, Cerecyte). Hydrogel-coated coils (HydroCoil): expand with hydration to improve packing density. Coil sizing: first coil ("framing coil") matches the aneurysm dome; subsequent coils progressively smaller ("filling" and "finishing" coils). Detachment mechanism: mechanical, electrolytic, or hydraulic.
Coiling Procedure
Position microcatheter tip in the aneurysm dome. Deploy framing coil along the inner wall of the dome to create a basket. Sequentially deploy filling coils within the basket. Finishing coils (softer, smaller) packed into remaining spaces. Target packing density: >25-30% (higher packing density → lower recurrence). Final angiography: confirm aneurysm occlusion, parent vessel patency, and absence of complications.
Adjunctive Techniques for Wide-Neck Aneurysms
| Technique | Mechanism | DAPT Required | Use in Acute SAH | Best Indication |
|---|---|---|---|---|
| Simple coiling | Coils alone fill dome | No | Yes | Narrow neck (D:N >2) |
| Balloon-assisted | Balloon across neck during deployment | No | Yes | Moderate wide neck |
| Stent-assisted | Permanent stent scaffold at neck | Yes (3-6+ months) | Limited | Wide neck, unruptured |
| Flow diversion | Dense stent diverts flow from dome | Yes (3-6+ months) | No | Large/giant, wide neck |
Balloon-assisted coiling (remodeling technique): Compliant balloon inflated across aneurysm neck during coil deployment. Prevents coil herniation into parent vessel. Balloon deflated between coil placements to assess parent vessel. Temporary occlusion only — balloon removed at end of procedure. Stent-assisted coiling: Self-expanding intracranial stent (LVIS, Enterprise, Neuroform) deployed across the aneurysm neck. Provides scaffold to retain coils. Requires dual antiplatelet therapy (DAPT) — limits use in acute SAH. Indicated for wide-neck unruptured aneurysms.
<image>Intraprocedural fluoroscopic image showing sequential coil deployment within an anterior communicating artery aneurysm using balloon-assisted technique with the compliant balloon inflated across the aneurysm neck</image>
Flow Diverters
Pipeline Embolization Device (PED) and Others
Densely woven, self-expanding stent placed across the aneurysm neck. Diverts flow away from the aneurysm → promotes thrombosis within the dome. Promotes endothelial overgrowth across the neck (neo-intima formation). Aneurysm thrombosis occurs gradually over weeks to months (not immediate). Primary indication: large/giant wide-neck ICA aneurysms (paraclinoid, cavernous). Expanding indications: selected posterior circulation aneurysms, small wide-neck aneurysms.
Key Considerations
Requires DAPT (aspirin + clopidogrel) for 3-6+ months. NOT used in acute SAH (DAPT risk). Complete aneurysm occlusion rates: 75-85% at 6 months, 85-95% at 1 year. Complications: delayed rupture (2-3%), in-stent thrombosis, perforator occlusion.
Scope of Practice Considerations
IR vs. Neuroradiology vs. Neurosurgery
Endovascular aneurysm treatment requires dedicated neurointerventional training beyond standard IR residency. Performed by: interventional neuroradiologists, endovascular neurosurgeons, and select neurointerventionalists with appropriate training. IR residents gain foundational catheter and fluoroscopy skills applicable to neurointerventional procedures. Fellowship training in neurointerventional surgery/radiology provides the specific competencies required.
Complications
Procedure-Related
Intraprocedural rupture (2-4% for ruptured aneurysms, <1% for unruptured): Immediately halt coil deployment, complete coil packing to tamponade. Reverse anticoagulation (protamine). EVD placement if hydrocephalus develops. Thromboembolic events (5-10%): Prevented by systemic heparinization during the procedure. Treated with intra-arterial tPA, glycoprotein IIb/IIIa inhibitors, or mechanical retrieval. Coil migration/herniation: into parent vessel; may require stent deployment as rescue. Parent vessel occlusion: from thrombus or coil mass. Vasospasm: from catheter manipulation.
Disease-Related (SAH)
Cerebral vasospasm (peaks days 4-14 after SAH). Hydrocephalus (acute or chronic). Rebleeding (before treatment). Delayed cerebral ischemia.
Follow-Up
MRA or DSA at 6 months, 1 year, then annually for 3-5 years. Assess for aneurysm recurrence/remnant growth. Coil compaction and aneurysm recurrence: 20-30% develop some degree of recanalization. Retreatment (re-coiling or flow diversion) needed in 10-15%. Contrast-enhanced MRA is the standard non-invasive follow-up modality (platinum coils cause minimal MRI artifact).
<image>Follow-up MRA at 6 months post-coiling showing complete occlusion of a previously treated posterior communicating artery aneurysm with patent parent ICA</image>
Clinical Pearls
ISAT established coiling as the first-line treatment for most ruptured aneurysms — clipping is reserved for MCA bifurcation aneurysms, very wide-neck aneurysms not amenable to endovascular treatment, and cases with concurrent hematoma requiring surgical evacuation. Dome-to-neck ratio is the single most important morphologic factor in determining whether simple coiling vs. adjunctive techniques are needed. Flow diverters have revolutionized treatment of large/giant paraclinoid ICA aneurysms — previously some of the most challenging aneurysms to treat. Dual antiplatelet therapy is mandatory with stent-assisted coiling and flow diversion — this limits their use in acute SAH where DAPT increases hemorrhagic risk. The higher retreatment rate with coiling compared with clipping is the trade-off for lower initial procedural morbidity — long-term follow-up imaging is essential. Intraprocedural rupture is the most feared complication — continue coil deployment to achieve tamponade; stopping and withdrawing the coil worsens the situation. For unruptured aneurysms, the decision to treat must balance procedural risk (1-2% morbidity) against the natural history of rupture (often <1%/year for small anterior circulation aneurysms). IR trainees should be familiar with aneurysm morphology, treatment principles, and SAH management even if they will not independently perform coiling — these cases are frequently discussed in multidisciplinary neurovascular conferences.
References
- Molyneux A, et al. International Subarachnoid Aneurysm Trial (ISAT): Overall Effect of Endovascular Coiling vs. Neurosurgical Clipping. Lancet. 2002;360(9342):1267-1274.
- Molyneux AJ, et al. ISAT: Long-Term Follow-Up at 18 Years. Lancet. 2015;385(9969):691-697.
- Spetzler RF, et al. The Barrow Ruptured Aneurysm Trial (BRAT): 6-Year Results. J Neurosurg. 2015;123(3):609-617.
- Becske T, et al. Pipeline for Uncoilable or Failed Aneurysms: Results from a Multicenter Clinical Trial (PUFS). Radiology. 2013;267(3):858-868.
- Greving JP, et al. Development of the PHASES Score for Prediction of Risk of Rupture of Intracranial Aneurysms. Lancet Neurol. 2014;13(1):59-66.
- Thompson BG, et al. Guidelines for the Management of Patients with Unruptured Intracranial Aneurysms (AHA/ASA). Stroke. 2015;46(8):2368-2400.
How to think about this
When considering intracranial aneurysms, it's crucial to understand the balance between their natural history and treatment risks. Not all aneurysms require intervention, and the decision is often multifactorial, taking into account size, location, morphology, and patient comorbidities. Endovascular coiling, while revolutionary, is a dynamic field with evolving techniques and devices, each with specific indications and limitations. The choice between simple coiling, balloon-assisted coiling, stent-assisted coiling, or flow diversion hinges on a careful assessment of aneurysm morphology, especially the neck width and dome-to-neck ratio, and the patient's acute presentation (ruptured vs. unruptured). Mastery of these principles is key to navigating appropriate patient management and understanding the nuances of neurointerventional practice.
Check yourself with 2 bullets.
- What is the primary factor that often pushes a neurointerventionalist toward adjunctive techniques (like balloon- or stent-assisted coiling) rather than simple coiling for an intracranial aneurysm?
- Why is dual antiplatelet therapy (DAPT) a critical consideration that limits the use of certain endovascular techniques (like flow diversion) in the acute setting of a subarachnoid hemorrhage?
